Works matching DE "PROGRAMMED cell death 1 receptors"
Results: 5000
Research trends and highlights in PD-1/PD-L1 inhibitor immunotherapy in lung cancer: a bibliometric analysis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02052-x
- By:
- Publication type:
- Article
Clinical Impact of Skeletal Muscle Mass and Nutritional Status in Patients with Recurrent or Advanced Gastric Cancer Treated with Nivolumab.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 192, doi. 10.1159/000540840
- By:
- Publication type:
- Article
The positive significance of skin complications after immunotherapy.
- Published in:
- Nowotwory, 2025, v. 75, n. 1, p. 45, doi. 10.5603/njo.101709
- By:
- Publication type:
- Article
Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13812-x
- By:
- Publication type:
- Article
Clinical efficacy and safety evaluation of traditional Chinese medicine for nourishing yin and Replenishing qi in combination with PD-1/PD-L1 inhibitors in the treatment of NSCLC patients: a meta-analysis.
- Published in:
- Toxicology Research, 2025, v. 14, n. 1, p. 1, doi. 10.1093/toxres/tfaf013
- By:
- Publication type:
- Article
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03612-7
- By:
- Publication type:
- Article
Are all programmed cell death protein 1 inhibitors the same?
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1535030
- By:
- Publication type:
- Article
A Critical Role of Intracellular PD-L1 in Promoting Ovarian Cancer Progression.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 4, p. 314, doi. 10.3390/cells14040314
- By:
- Publication type:
- Article
Molecular Insights into Cell-Mediated Immunity in Atypical Non-Ulcerated Cutaneous Leishmaniasis.
- Published in:
- Microorganisms, 2025, v. 13, n. 2, p. 413, doi. 10.3390/microorganisms13020413
- By:
- Publication type:
- Article
Electroacupuncture Modulates Programmed Cell Death 1 Ligand 1 on Peripheral and Central Nervous Systems in a Mouse Fibromyalgia Pain Model.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 396, doi. 10.3390/biomedicines13020396
- By:
- Publication type:
- Article
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1200, doi. 10.3390/jcm14041200
- By:
- Publication type:
- Article
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1513394
- By:
- Publication type:
- Article
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 118, doi. 10.3390/curroncol32020118
- By:
- Publication type:
- Article
ESVONC abstracts.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, p. 3, doi. 10.1111/vco.13009
- Publication type:
- Article
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 4, p. 709, doi. 10.1111/vco.12934
- By:
- Publication type:
- Article
Regulation of programmed death ligand 1 expression by interferon‐γ and tumour necrosis factor‐α in canine tumour cell lines.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 279, doi. 10.1111/vco.12886
- By:
- Publication type:
- Article
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 255, doi. 10.1111/vco.12884
- By:
- Publication type:
- Article
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 4, p. 901, doi. 10.1111/vco.12829
- By:
- Publication type:
- Article
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 427, doi. 10.1111/vco.12788
- By:
- Publication type:
- Article
Characterizing the molecular and immune landscape of canine bladder cancer.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 69, doi. 10.1111/vco.12740
- By:
- Publication type:
- Article
Abstracts‐Posters.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, p. 4, doi. 10.1111/vco.12764
- Publication type:
- Article
Checkpoint molecule expression by B and T cell lymphomas in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 352, doi. 10.1111/vco.12386
- By:
- Publication type:
- Article
Immune regulation of canine tumour and macrophage PD-L1 expression.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 534, doi. 10.1111/vco.12197
- By:
- Publication type:
- Article
Smart Phototheranostics based on Carbon Nanohorns for Precise Imaging‐Guided Post‐PDT toward Residual Tumor Cells after Initial Phototherapy.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 8, p. 1, doi. 10.1002/chem.202203196
- By:
- Publication type:
- Article
In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 4, p. 1, doi. 10.1002/ange.202315282
- By:
- Publication type:
- Article
Click‐Chemistry‐Mediated Cell Membrane Glycopolymer Engineering to Potentiate Dendritic Cell Vaccines.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 2, p. 1, doi. 10.1002/ange.202315782
- By:
- Publication type:
- Article
Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 52, p. 1, doi. 10.1002/ange.202312609
- By:
- Publication type:
- Article
Metal‐DNA Nanocomplexes Enhance Chemo‐dynamic Therapy by Inhibiting Autophagy‐Mediated Resistance.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 50, p. 1, doi. 10.1002/ange.202307020
- By:
- Publication type:
- Article
A Semiconducting Iron‐Chelating Nano‐immunomodulator for Specific and Sensitized Sono‐metallo‐immunotherapy of Cancer.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 43, p. 1, doi. 10.1002/ange.202310178
- By:
- Publication type:
- Article
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 30, p. 1, doi. 10.1002/ange.202305200
- By:
- Publication type:
- Article
Glutathione‐Induced In Situ Michael Addition between Nanoparticles for Pyroptosis and Immunotherapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 20, p. 1, doi. 10.1002/ange.202301866
- By:
- Publication type:
- Article
Selective Synthesis and Structural Transformation of a 4‐Ravel Containing Four Crossings and Featuring Cp*Rh/Ir Fragments.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 20, p. 1, doi. 10.1002/ange.202301516
- By:
- Publication type:
- Article
Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium‐Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 19, p. 1, doi. 10.1002/ange.202216822
- By:
- Publication type:
- Article
A Polymeric Extracellular Matrix Nanoremodeler for Activatable Cancer Photo‐Immunotherapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 12, p. 1, doi. 10.1002/ange.202217339
- By:
- Publication type:
- Article
Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 11, p. 1, doi. 10.1002/ange.202218128
- By:
- Publication type:
- Article
Multimodal Imaging‐Guided Photothermal Immunotherapy Based on a Versatile NIR‐II Aggregation‐Induced Emission Luminogen.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 27, p. 1, doi. 10.1002/ange.202202614
- By:
- Publication type:
- Article
Deep Downregulation of PD‐L1 by Caged Peptide‐Conjugated AIEgen/miR‐140 Nanoparticles for Enhanced Immunotherapy.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 18, p. 1, doi. 10.1002/ange.202117798
- By:
- Publication type:
- Article
Single‐Atom Pd Nanozyme for Ferroptosis‐Boosted Mild‐Temperature Photothermal Therapy.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 23, p. 13081, doi. 10.1002/ange.202101924
- By:
- Publication type:
- Article
Frontispiz: Biomimetic Nanoemulsion for Synergistic Photodynamic‐Immunotherapy Against Hypoxic Breast Tumor.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 19, p. 1, doi. 10.1002/ange.202181962
- By:
- Publication type:
- Article
Biomimetic Nanoemulsion for Synergistic Photodynamic‐Immunotherapy Against Hypoxic Breast Tumor.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 19, p. 10742, doi. 10.1002/ange.202015590
- By:
- Publication type:
- Article
Polyphenol‐Based Nanomedicine Evokes Immune Activation for Combination Cancer Treatment.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 4, p. 1995, doi. 10.1002/ange.202013406
- By:
- Publication type:
- Article
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX‐2 and PD‐L1.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 51, p. 23513, doi. 10.1002/ange.202011273
- By:
- Publication type:
- Article
Improving Cancer Immunotherapy Outcomes Using Biomaterials.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 40, p. 17484, doi. 10.1002/ange.202002780
- By:
- Publication type:
- Article
A Novel d‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 35, p. 15226, doi. 10.1002/ange.202002783
- By:
- Publication type:
- Article
Cysteine/Penicillamine Ligation Independent of Terminal Steric Demands for Chemical Protein Synthesis.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 31, p. 12741, doi. 10.1002/anie.202003652
- By:
- Publication type:
- Article
Homogeneous, Low‐volume, Efficient, and Sensitive Quantitation of Circulating Exosomal PD‐L1 for Cancer Diagnosis and Immunotherapy Response Prediction.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 12, p. 4830, doi. 10.1002/ange.201916039
- By:
- Publication type:
- Article
NIR‐II Driven Plasmon‐Enhanced Catalysis for a Timely Supply of Oxygen to Overcome Hypoxia‐Induced Radiotherapy Tolerance.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 42, p. 15213, doi. 10.1002/ange.201906758
- By:
- Publication type:
- Article
Vibration properties of immune‐oncological drugs.
- Published in:
- Journal of Raman Spectroscopy, 2022, v. 53, n. 4, p. 715, doi. 10.1002/jrs.6297
- By:
- Publication type:
- Article
Micro Raman spectroscopy for NETosis detection.
- Published in:
- Journal of Raman Spectroscopy, 2020, v. 51, n. 10, p. 1960, doi. 10.1002/jrs.5844
- By:
- Publication type:
- Article
Investigation of the Role of Hydrophobic Amino Acids on the Structure–Activity Relationship in the Antimicrobial Venom Peptide Ponericin L1.
- Published in:
- Journal of Membrane Biology, 2022, v. 255, n. 4/5, p. 537, doi. 10.1007/s00232-021-00204-y
- By:
- Publication type:
- Article